Cardiotech News (AMEX:CTE)
| Latest Cardiotech News Headlines | | Date | Time | Source | | | 02/05/2008 | 2:12PM | PRNUS | CardioTech Announces Conference Call on February 12 at 2:30 PM Eastern for Third Quarter of Fiscal 2008
WILMINGTON, Mass., Feb. 5 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it will release its fiscal 2008 third quarter financial results before the... More...>> |
| 01/22/2008 | 10:51AM | PRNUS | CardioTech to Showcase its Innovative Technology at MD&M West Expo on January 29-31
WILMINGTON, Mass., Jan. 22 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of a broad range of disease states, today announced that it will be showcasing its innovative technology at the world's largest medical... More...>> |
| 11/13/2007 | 8:30AM | PRNUS | CardioTech International Reports Fiscal Second Quarter Financial Results
WILMINGTON, Mass., Nov. 13 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced medical devices and materials for the treatment of a broad range of disease states, today reported financial results for the fiscal second quarter and six months ended September 30... More...>> |
| 11/05/2007 | 2:00PM | PRNUS | CardioTech Announces Conference Call on November 13 at 2:30 PM Eastern For Second Quarter of Fiscal 2008
WILMINGTON, Mass., Nov. 5 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it will release its fiscal 2008 second quarter financial results before the... More...>> |
| 10/23/2007 | 8:03AM | PRNUS | CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
Preclinical Studies of Valecor Platinum(TM) Coronary Stent System Indicate Positive Results and Improvements Compared to Market-Leading Bare Stent
BURLINGTON, Mass., Oct. 23 /PRNewswire/ -- CorNova, Inc. announced today that S. Eric Ryan, M.D., Chairman & CEO of CorNova, presented preliminary results of its recent preclinical... More...>> |
| 08/23/2007 | 12:00PM | PRNUS | CardioTech Announces Webcast of its Noble Financial Conference Presentation
WILMINGTON, Mass., Aug. 23 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices, announced today that the webcast of President & CEO Michael Adams presentation at the recent Noble Financial Small Cap Conference can now be accessed... More...>> |
| 08/13/2007 | 8:30AM | PRNUS | CardioTech International's Fiscal First Quarter 08 Results Continue to Show Improved Performance
WILMINGTON, Mass., Aug. 13 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced medical device products for the treatment of cardiovascular and other diseases, today reported financial results for the fiscal first quarter ended June 30, 2007. The Company's financial... More...>> |
| 08/06/2007 | 11:54AM | PRNUS | CardioTech Announces Conference Call on August 13 at 2:30 PM Eastern For First Quarter of Fiscal 2008
Management to Present at Noble Financial Conference August 20-21
WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer of advanced polymer materials and manufacturer of medical products for the treatment and diagnosis of a broad range of disease states, announced... More...>> |
| 07/09/2007 | 3:01PM | PRNUS | CardioTech's Sale of Gish Biomedical to Medos Medizintechnik AG Has Been Completed
WILMINGTON, Mass., July 9 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that its agreement to sell its Gish Biomedical, Inc. subsidiary in a stock transaction... More...>> |
| 07/05/2007 | 10:30AM | PRNUS | CardioTech Announces Agreement to Sell Gish Biomedical to Medos Medizintechnik AG for a Purchase Price of $7.5 Million
Net Cash Proceeds to be Used for CardioTech's Growth Initiatives
WILMINGTON, Mass., July 5 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it has signed... More...>> |
| 06/27/2007 | 8:30AM | PRNUS | CardioTech International's Fiscal 2007 Results Show Improved Performance in the Fourth Quarter
WILMINGTON, Mass., June 27 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced medical device products for the treatment of cardiovascular and other diseases, today reported financial results for the fiscal fourth quarter and year ended March 31, 2007.
(Logo:... More...>> |
| 06/21/2007 | 9:00AM | PRNUS | CardioTech Announces Conference Call on June 27 at 2:30 PM Eastern For Fiscal Year 2007
WILMINGTON, Mass., June 21 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it will release its fiscal fourth quarter and year end 2007 financial results... More...>> |
| 06/18/2007 | 1:00PM | PRNUS | CardioTech Announces Patent Filing for Antimicrobial Polymers Designed to Avoid Infections Without Using Antibiotic Drugs
WILMINGTON, Mass., June 18 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it has filed for a US patent on its proprietary antimicrobial formulation... More...>> |
| 04/04/2007 | 10:30AM | PRNUS | CardioTech Showcases Breadth of Innovative Medical Device Technology, Products and Services with New Website and Expanded Strate
WILMINGTON, Mass., April 4 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a leader in materials science technology, medical device engineering services and contract manufacturing, today launched a new website http://www.cardiotech-inc.com/. The new website provides easy access to CardioTech's... More...>> |
| 03/22/2007 | 10:00AM | PRNUS | CardioTech Reports First Surgical Implant of CardioPass; Patient Has Been Discharged from Hospital
WILMINGTON, Mass., March 22 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced medical device materials and products for the treatment of cardiovascular and other diseases, today reported that the first patient in its European clinical trial of CardioPass(TM... More...>> |
| 02/15/2007 | 8:30AM | PRNUS | CardioTech Reports Fiscal Third Quarter & Nine Month 2007 Results; Company Retains Investment Banking Firm to Manage Sale of its
WILMINGTON, Mass., Feb. 15 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, today reported financial results for the third quarter and nine months of fiscal 2007 ended December... More...>> |
| 02/06/2007 | 2:56PM | PRNUS | CorNova Completes Financing
BURLINGTON, Mass., Feb. 6 /PRNewswire/ -- CorNova, Inc., a privately held developer of advanced endovascular devices and catheters, reported that it completed a private financing through the sale of 950,000 shares of Series A Preferred Convertible Stock at $2.50 per share with total gross proceeds of $2,375,000... More...>> |
| 02/06/2007 | 10:30AM | PRNUS | CardioTech Announces Fiscal Third Quarter 2007 Conference Call on February 15 at 2:30 PM Eastern
Integrated Marketing Launch at MDM Expo on February 13
WILMINGTON, Mass., Feb. 6 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it will release its... More...>> |
| 01/30/2007 | 1:34PM | PRNUS | CardioTech Reports Clinical Trial is Underway for CardioPass(TM) After Receipt of FDA Export License for Synthetic Coronary Bypa
WILMINGTON, Mass., Jan. 30 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced medical device materials and products for the treatment of cardiovascular and other diseases, today reported that its European clinical trial of CardioPass(TM), the Company's proprietary... More...>> |
| 12/20/2006 | 10:30AM | PRNUS | CorNova Receives CE Mark for Its Valecor(TM) Coronary Stent System
BURLINGTON, Mass., Dec. 20 /PRNewswire-FirstCall/ -- CorNova, Inc., a developer of advanced endovascular devices and catheters, and CardioTech International, Inc. (AMEX:CTE) today reported that CorNova GmbH, a wholly- owned German subsidiary of CorNova, Inc., has received CE Mark marketing approval for its Valecor(TM... More...>> |
|
|
|